Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer.

@article{PenaultLlorca2009Ki67EA,
  title={Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer.},
  author={Fr{\'e}d{\'e}rique Penault-Llorca and Fabrice Andr{\'e} and Christine Sagan and Magali Lacroix-Triki and Yves Denoux and V{\'e}ronique Verri{\`e}le and Jocelyne D. Jacquemier and Marie Christine Baranzelli and Fr{\'e}d{\'e}ric Bibeau and Martine Antoine and Nicole Lagarde and A Martin and Bernard Asselain and Henri Roch{\'e}},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 17},
  pages={2809-15}
}
PURPOSE The indications of adjuvant chemotherapy for patients with estrogen receptor (ER) -positive breast cancer are controversial. We analyzed the predictive value of Ki67, HER2, and progesterone receptor (PR) expression for the efficacy of docetaxel in patients with ER-positive, node-positive breast cancer. PATIENTS AND METHODS Expression of Ki67, HER2, and PR was measured by immunohistochemistry in tumor samples from 798 patients with ER-positive breast cancer who participated in PACS01, a… CONTINUE READING
102 Extracted Citations
25 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 102 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 25 references

10 th St . Gallen conference : Progress and promise — Highlights of the international expert consensus on the primary therapy of early breast cancer 2007

  • G Tomasic
  • Ann Oncol
  • 2007

Similar Papers

Loading similar papers…